Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India · Delayed Price · Currency is INR 1,807.70
+13.50 (0.75%)
Jun 12, 2026, 3:29 PM IST
NSE:SUNPHARMA Revenue
In the fiscal year ending March 31, 2026, Sun Pharmaceutical Industries had annual revenue of 584.62B INR with 11.19% growth. Sun Pharmaceutical Industries had revenue of 146.12B in the quarter ending March 31, 2026, with 12.76% growth.
Revenue
584.62B
Revenue Growth
+11.19%
P/S Ratio
7.42
Revenue / Employee
13.60M
Employees
43,000
Market Cap
4.34T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 584.62B | 58.84B | 11.19% |
| Mar 31, 2025 | 525.78B | 40.82B | 8.42% |
| Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
| Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
| Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 336.53B |
| Cipla | 278.28B |
| Zydus Lifesciences | 271.48B |
| Glenmark Pharmaceuticals | 169.83B |
| Alkem Laboratories | 147.12B |
| Mankind Pharma | 142.78B |
| Divi's Laboratories | 105.60B |
| Ipca Laboratories | 96.46B |
Sun Pharmaceutical Industries News
- 2 days ago - Sun Pharmaceutical sets Rs 5 per share final dividend with July 7 record date - Business Upturn
- 5 days ago - Nifty 50 top gainers in morning trades today, June 8: Apollo Hospitals up 1.0%, SBI gains 0.8%, Sun Pharma rises 0.6% - Business Upturn
- 17 days ago - Sun Pharma share price target: Brokerages remain positive on specialty growth and strong India business - Business Upturn
- 18 days ago - Sun Pharma To Present Long-Term Follow-up Data On UNLOXCYT - Nasdaq
- 19 days ago - Pharma Sector Stocks Today, May 25: Torrent Pharma up 4.23%, Glenmark Pharma gains 4%, Sun Pharma down 0.31% - Business Upturn
- 22 days ago - Sun Pharmaceutical Industries Transcript: Q4 25/26 - Transcripts
- 22 days ago - Sun Pharmaceutical Industries Quarterly report: Q4 2026 - Filings
- 22 days ago - Sun Pharma Q4 Results: Net profit rises 26.2% YoY, EBITDA grows over 6% - Business Upturn